Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer

Élisabeth Quoix, B Lebeau, Alain Depierre et al. · Annals of Oncology · 2003

Cited by 41 works. doi:10.1093/annonc/mdh005

Authors

References